← Back to Patent Explorer
US4063014A Expired / Lapsed US ⏱️ 0.0 years remaining

4"-O-sulfonyl erythromycin-9-O-oxime derivatives

Assignee: Abbott Laboratories
•
Filing: 1975-06-12
•
Granted: 1977-12-13
•
Expires: 1995-06-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A 4"-O-sulfonyl erythromycin derivative of the following structural formula: ##STR1## where R is selected from the group consisting of oxygen, oxime, and substituted oxime, R 1 is hydrogen or hydroxy and R 2 is selected from the group consisting of phthalimide, substituted amides, benzamides, substituted benzamides, sulfonamides, substituted sulfonamides, amines, substituted amines, phenylurea, substituted phenylurea, phenylthiourea, substituted phenylthiourea, thiophenol and substituted thiophenol, phenoxides and substituted phenoxides and R 3 is hydrogen or methyl. The present sulfonyl derivatives of erythromycin A, B and C are useful as antibiotics.

Inventors

  • 👤 Robert Hallas
  • 👤 Jerry Roy Martin
  • 👤 John Soloman Tadanier

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 16:43
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 54 words
A 4"-O-sulfonyl erythromycin derivative of the following structural formula: ##STR4## wherein R is methyloxime, R 1 is hydrogen or hydroxy and R 2 is, phthalimido, alkanoylamido, nitro- or amino-substituted-benzoylamido or -benzenesulfamido, phenyl-ureido or -thioureido wherein said phenyl group may carry dimethylamino, methoxy, chloro or nitro, or CBZ-glycylamido and R 3 is hydrogen or methyl.
Claim 2
Dependent Claim 54 words
A 4"-O-sulfonyl erythromycin derivative of the following structural formula: ##STR4## wherein R is methyloxime, R 1 is hydrogen or hydroxy and R 2 is, phthalimido, alkanoylamido, nitro- or amino-substituted-benzoylamido or -benzenesulfamido, phenyl-ureido or -thioureido wherein said phenyl group may carry dimethylamino, methoxy, chloro or nitro, or CBZ-glycylamido and R 3 is hydrogen or methyl.
Claim 3
Dependent Claim 19 words
A compound according to claim 1 wherein R 1 and R 3 are hydrogen and R 2 is phthalimido.
Claim 4
Dependent Claim 22 words
A compound according to claim 1 where R 1 is hydrogen, R 3 is methyl and R 2 is a substituted phenylthiourea.
Claim 5
Dependent Claim 22 words
A compound according to claim 1 wherein R 1 is hydroxy, R 3 is methyl and R 2 is a substituted phenylthiourea.
Claim 6
Dependent Claim 22 words
A compound according to claim 1 wherein R 1 is hydrogen, R 3 is methyl and R 2 is a substituted phenylurea.
Claim 7
Dependent Claim 25 words
A compound according to claim 1 wherein R is methyloxime, R 1 is hydroxy, R 3 is methyl and R 2 is a substituted phenylurea.

References Cited (Backward Citations)

US3869445A Cited
US3836819A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-12-12 1981-06-13 1981-12-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-12-12 1985-06-13 1985-12-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-12-12 1989-06-13 1989-12-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag